BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32018151)

  • 21. Clinical spectrum of dopa-responsive dystonia and related disorders.
    Lee WW; Jeon BS
    Curr Neurol Neurosci Rep; 2014 Jul; 14(7):461. PubMed ID: 24844652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.
    Furukawa Y; Graf WD; Wong H; Shimadzu M; Kish SJ
    Neurology; 2001 Jan; 56(2):260-3. PubMed ID: 11160968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dystonia-plus syndromes.
    Asmus F; Gasser T
    Eur J Neurol; 2010 Jul; 17 Suppl 1():37-45. PubMed ID: 20590807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mutations in the tyrosine hydroxylase gene in the first Czech patient with tyrosine hydroxylase deficiency.
    Szentiványi K; Hansíková H; Krijt J; Vinšová K; Tesařová M; Rozsypalová E; Klement P; Zeman J; Honzík T
    Prague Med Rep; 2012; 113(2):136-46. PubMed ID: 22691284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.
    Stamelou M; Mencacci NE; Cordivari C; Batla A; Wood NW; Houlden H; Hardy J; Bhatia KP
    Neurology; 2012 Jul; 79(5):435-41. PubMed ID: 22815559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [TH gene mutation in Chinese patients with autosomal recessive dopa-responsive dystonia].
    Liu W; Tang BS; Cao GF; Chen T; Li HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):452-4. PubMed ID: 15476168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
    Furukawa Y; Kish SJ; Fahn S
    Ann Neurol; 2004 Jan; 55(1):147-8. PubMed ID: 14705130
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dopa-responsive dystonia (Segawa syndrome) with secondary skeleton deformity].
    Budrewicz SP; Góral M; Koszewicz M; Tarantowicz P; Podemski R
    Wiad Lek; 2006; 59(9-10):713-5. PubMed ID: 17338136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Compound Heterozygote for GCH1 Mutation Represents a Case of Atypical Dopa-Responsive Dystonia.
    Giri S; Naiya T; Roy S; Das G; Wali GM; Das SK; Ray K; Ray J
    J Mol Neurosci; 2019 Jun; 68(2):214-220. PubMed ID: 30911941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course.
    Giovanniello T; Leuzzi V; Carducci C; Carducci C; Sabato ML; Artiola C; Santagata S; Pozzessere S; Antonozzi I
    Neuropediatrics; 2007 Aug; 38(4):213-5. PubMed ID: 18058633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population.
    van den Heuvel LP; Luiten B; Smeitink JA; de Rijk-van Andel JF; Hyland K; Steenbergen-Spanjers GC; Janssen RJ; Wevers RA
    Hum Genet; 1998 Jun; 102(6):644-6. PubMed ID: 9703425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.
    Furukawa Y; Nygaard TG; Gütlich M; Rajput AH; Pifl C; DiStefano L; Chang LJ; Price K; Shimadzu M; Hornykiewicz O; Haycock JW; Kish SJ
    Neurology; 1999 Sep; 53(5):1032-41. PubMed ID: 10496263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
    Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal Genetic Testing for Dopa-Responsive Dystonia - Clinical Judgment in the Context of Next Generation Sequencing.
    Nedelea F; Veduta A; Duta S; Vayna AM; Panaitescu A; Peltecu G; Duba HC
    J Med Life; 2018; 11(4):343-345. PubMed ID: 30894892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1.
    Jung-Klawitter S; Richter P; Yuan Y; Welzel K; Kube M; Bähr S; Leibner A; Flory E; Opladen T
    J Inherit Metab Dis; 2024 May; 47(3):517-532. PubMed ID: 38084654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Child Neurology: A young child with an undiagnosed case of dystonia responsive to l-dopa.
    Trau SP; Gallentine WB; Mikati MA
    Neurology; 2020 Feb; 94(7):326-328. PubMed ID: 32015175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
    Kawahata I; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein.
    Royo M; Daubner SC; Fitzpatrick PF
    Proteins; 2005 Jan; 58(1):14-21. PubMed ID: 15468323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase.
    Flydal MI; Kråkenes TA; Tai MDS; Tran MPA; Teigen K; Martinez A
    Biochimie; 2021 Apr; 183():126-132. PubMed ID: 33309753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.